JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120009

PPADS, P2 purinergic receptor antagonist

Be the first to review this product! Submit a review

|

(11 Publications)

MW 599.3 Da. Achieve your results faster with highly validated, pure and trusted compounds.
4 Images
Functional Studies - PPADS, P2 purinergic receptor antagonist (AB120009)
  • FuncS

PubMed

Functional Studies - PPADS, P2 purinergic receptor antagonist (AB120009)

Ca2+ signal from a field A neuron, a field B neuron, and field A astrocytes in response to repetitive episodes of NMDA stimulation (black arrowheads). The NMDA stimulation that evoked an ictal discharge became ineffective after blocking the astrocyte response by bath perfusion with MPEP (ab120008) and PPADS (ab120009). An ictal discharge could be recovered by increasing the number of NMDA puffs (white arrowheads). A double NMDA pulse evoked both astrocyte activation and the ictal discharge after inhibitor washout.

Image from Gómez-Gonzalo M et al., PLoS Biol. 2010;8(4):e1000352. Fig 6(A).; doi: 10.1371/journal.pbio.1000352.

Functional Studies - PPADS, P2 purinergic receptor antagonist (AB120009)
  • FuncS

PubMed

Functional Studies - PPADS, P2 purinergic receptor antagonist (AB120009)

Astrocyte Ca2+ signal inhibition does not affect interictal discharges.

(A–D) Mean percentage of astrocytes activated by the ictal discharges (A), mean duration (B) and frequency (C) of the ictal discharge, and mean frequency of interictal discharges (D) under different experimental conditions in EC slice preparations. Controls (n=16), MPEP (ab120008) (n=7), PPADS (ab120009) (n=9), and MPEP+PPADS (n=3). A single asterisk (*) indicates p<0.05; double asterisks (**), p<0.01.

Image from Gómez-Gonzalo M et al., PLoS Biol. 2010;8(4):e1000352. Fig 2.; doi: 10.1371/journal.pbio.1000352. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/

Chemical Structure - PPADS, P2 purinergic receptor antagonist (AB120009)
  • Chemical Structure

Lab

Chemical Structure - PPADS, P2 purinergic receptor antagonist (AB120009)

2D chemical structure image of ab120009, PPADS, P2 purinergic receptor antagonist

Cellular Activation - PPADS, P2 purinergic receptor antagonist (AB120009)
  • CellAct

Unknown

Cellular Activation - PPADS, P2 purinergic receptor antagonist (AB120009)

Inhibition by suramin and PPADS significantly reduces the ATP-induced increase in extracellular H+ flux from isolated Müller cells.
Mean responses to 10 μM ATP with or without suramin and PPADS in the bath; N = 7, error bars represent SEMs.

Image from Tchernookova B, et al. Plos One, 13(2), e0190893. Fig 2c,; doi: 10.1371/journal.pone.0190893

Key facts

CAS number

192575-19-2

Form

Solid

form

Molecular weight

599.3 Da

Molecular formula

C<sub>1</sub><sub>4</sub>H<sub>1</sub><sub>0</sub>N<sub>3</sub>Na<sub>4</sub>O<sub>1</sub><sub>2</sub>PS<sub>2</sub>

PubChem

135484645

Nature

Synthetic

Solubility

Soluble in water to 100 mM

Biochemical name

Ppads tetrasodium salt

Canonical smiles

CC1=C(C(=C(C(=N1)N=NC2=C(C=C(C=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])COP(=O)([O-])[O-])C=O)O.[Na+].[Na+].[Na+].[Na+]

InChi

InChI=1S/C14H14N3O12PS2.4Na/c1-7-13(19)9(5-18)10(6-29-30(20,21)22)14(15-7)17-16-11-3-2-8(31(23,24)25)4-12(11)32(26,27)28;;;;/h2-5,19H,6H2,1H3,(H2,20,21,22)(H,23,24,25)(H,26,27,28);;;;/q;4*+1/p-4

IUPAC Name

tetrasodium;4-[[4-formyl-5-hydroxy-6-methyl-3-(phosphonatooxymethyl)pyridin-2-yl]diazenyl]benzene-1,3-disulfonate

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (11)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 15:5759 PubMed38982116

2024

Metabolic reprograming mediated by tumor cell-intrinsic type I IFN signaling is required for CD47-SIRPα blockade efficacy.

Applications

Unspecified application

Species

Unspecified reactive species

Hang Zhou,Wenjun Wang,Hairong Xu,Yong Liang,Jiyu Ding,Mengjie Lv,Boyang Ren,Hua Peng,Yang-Xin Fu,Mingzhao Zhu

Biophysics and physicobiology 19:e190041 PubMed36349331

2022

Influence of gap junctions upon Ca propagation from stimulated keratinocytes to DRG neurons.

Applications

Unspecified application

Species

Unspecified reactive species

Chiaki Seto,Kenta Toyoda,Kousuke Inada,Kotaro Oka,Etsuro Ito

Scientific reports 11:15129 PubMed34301999

2021

Adenosine deaminase modulates metabolic remodeling and orchestrates joint destruction in rheumatoid arthritis.

Applications

Unspecified application

Species

Unspecified reactive species

Sai Krishna Srimadh Bhagavatham,Prakash Khanchandani,Vishnu Kannan,Damodaram Potikuri,Divya Sridharan,Sujith Kumar Pulukool,Ashwin Ashok Naik,Rajesh Babu Dandamudi,Sai Mangala Divi,Ashish Pargaonkar,Rahul Ray,Saibharath Simha Reddy Santha,Polani B Seshagiri,K Narasimhan,Narsimulu Gumdal,Venketesh Sivaramakrishnan

Scientific reports 11:9766 PubMed33963197

2021

Elevated dimethylarginine, ATP, cytokines, metabolic remodeling involving tryptophan metabolism and potential microglial inflammation characterize primary open angle glaucoma.

Applications

Unspecified application

Species

Unspecified reactive species

Sujith Kumar Pulukool,Sai Krishna Srimadh Bhagavatham,Vishnu Kannan,Piruthivi Sukumar,Rajesh Babu Dandamudi,Shamika Ghaisas,Haripriya Kunchala,Darshan Saieesh,Ashwin Ashok Naik,Ashish Pargaonkar,Anuj Sharma,Venketesh Sivaramakrishnan

Glia 67:78-90 PubMed30306657

2018

Overexpression of P2X4 receptor in Schwann cells promotes motor and sensory functional recovery and remyelination via BDNF secretion after nerve injury.

Applications

Unspecified application

Species

Unspecified reactive species

Wen-Feng Su,Fan Wu,Zi-Han Jin,Yun Gu,Ying-Ting Chen,Ying Fei,Hui Chen,Ya-Xian Wang,Ling-Yan Xing,Ya-Yu Zhao,Ying Yuan,Xin Tang,Gang Chen

PloS one 13:e0190893 PubMed29466379

2018

Activation of retinal glial (Müller) cells by extracellular ATP induces pronounced increases in extracellular H+ flux.

Applications

Unspecified application

Species

Unspecified reactive species

Boriana K Tchernookova,Chad Heer,Marin Young,David Swygart,Ryan Kaufman,Michael Gongwer,Lexi Shepherd,Hannah Caringal,Jason Jacoby,Matthew A Kreitzer,Robert Paul Malchow

Scientific reports 5:16895 PubMed26592929

2015

Biophysical Regulation of Chromatin Architecture Instills a Mechanical Memory in Mesenchymal Stem Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Su-Jin Heo,Stephen D Thorpe,Tristan P Driscoll,Randall L Duncan,David A Lee,Robert L Mauck

Journal of neurophysiology 114:159-69 PubMed25904713

2015

ATP stimulates rat hypothalamic sympathetic neurons by enhancing AMPA receptor-mediated currents.

Applications

Unspecified application

Species

Unspecified reactive species

Hildebrando Candido Ferreira-Neto,Vagner R Antunes,Javier E Stern

British journal of pharmacology 162:974-88 PubMed21054344

2010

Purine receptor-mediated endocannabinoid production and retrograde synaptic signalling in the cerebellar cortex.

Applications

Unspecified application

Species

Unspecified reactive species

Flora E Kovacs,Peter Illes,Bela Szabo

PLoS biology 8:e1000352 PubMed20405049

2010

An excitatory loop with astrocytes contributes to drive neurons to seizure threshold.

Applications

Unspecified application

Species

Unspecified reactive species

Marta Gómez-Gonzalo,Gabriele Losi,Angela Chiavegato,Micaela Zonta,Mario Cammarota,Marco Brondi,Francesco Vetri,Laura Uva,Tullio Pozzan,Marco de Curtis,Gian Michele Ratto,Giorgio Carmignoto
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com